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Background: Meta-analyses are particularly vulnerable to the effects of publication bias. Despite methodologists’
best efforts to locate all evidence for a given topic the most comprehensive searches are likely to miss unpublished
studies and studies that are published in the gray literature only. If the results of the missing studies differ
systematically from the published ones, a meta-analysis will be biased with an inaccurate assessment of the
intervention’s effects.
As part of the OPEN project (www.open-project.eu) we will conduct a systematic review with the following
objectives:
▪ To assess the impact of studies that are not published or published in the gray literature on pooled effect
estimates in meta-analyses (quantitative measure).
▪ To assess whether the inclusion of unpublished studies or studies published in the gray literature leads to
different conclusions in meta-analyses (qualitative measure).
Methods/Design: Inclusion criteria: Methodological research projects of a cohort of meta-analyses which compare
the effect of the inclusion or exclusion of unpublished studies or studies published in the gray literature.
Literature search: To identify relevant research projects we will conduct electronic searches in Medline, Embase and
The Cochrane Library; check reference lists; and contact experts.
Outcomes: 1) The extent to which the effect estimate in a meta-analyses changes with the inclusion or exclusion of
studies that were not published or published in the gray literature; and 2) the extent to which the inclusion of
unpublished studies impacts the meta-analyses’ conclusions.
Data collection: Information will be collected on the area of health care; the number of meta-analyses included in
the methodological research project; the number of studies included in the meta-analyses; the number of study
participants; the number and type of unpublished studies; studies published in the gray literature and published
studies; the sources used to retrieve studies that are unpublished, published in the gray literature, or commercially
published; and the validity of the methodological research project.
Data synthesis: Data synthesis will involve descriptive and statistical summaries of the findings of the included
methodological research projects.
Discussion: Results are expected to be publicly available in the middle of 2013.
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A meta-analyses as part of a systematic review aims to
provide a thorough, comprehensive and unbiased ac-
count of the literature [1,2]. However, potentially im-
portant studies could be missing from a meta-analysis
because of selective publication and inadequate dissem-
ination of results. Despite methodologists’ best efforts
to locate all eligible evidence for a given topic the
most comprehensive searches are likely to miss un-
published studies and studies that are not commer-
cially published and, therefore, are not indexed in
respective databases (so called gray literature, such as
conference abstract, dissertations, policy documents,
book chapters). If the results from missing studies
differ systematically from the published data, a meta-
analysis may become biased with an inaccurate as-
sessment of the intervention’s effects. For instance,
positive, significant findings are more likely to be
published than non-significant findings, and a meta-
analysis which is based mainly on published literature
may end up overestimating the efficacy of the inter-
vention [3-5].
However, the impact of gray literature and unpub-
lished studies on the conclusions of meta-analyses has
not been comprehensively clarified. For example, there
is some evidence that suggests that published random-
ized controlled trials (RCTs) tend to be larger and show
an overall greater treatment effect than gray trials [6].
But the identification of relevant unpublished studies or
studies published in the gray literature and their
inclusion in meta-analyses can be particularly time-
consuming and challenging. There is also some contro-
versy as to whether unpublished studies and studies
published in the gray literature should be included in
meta-analyses because they might be incomplete and
their methodological quality (validity) can be difficult to
assess. A publication by Cook and colleagues in 1993
showed that 78% of authors of meta-analyses felt that
unpublished studies should be included in meta-analyses
compared to only 47% of journal editors [7]. Therefore,
research is needed to help assess the potential implica-
tions for reviewers of not including gray literature and
unpublished studies in meta-analyses of health care
interventions.
Objectives
In terms of the above mentioned controversies regarding
the inclusion of unpublished studies and studies pub-
lished in the gray literature on the results of meta-
analyses, we will conduct a systematic review with the
following objectives:
▪ To assess the impact of studies that were not
published or only published in the gray literature onpooled effect estimates in meta-analyses (quantitative
measure)
▪ To assess whether the inclusion of unpublished
studies or studies published in the gray literature
impacts the conclusions of meta-analyses (qualitative
measure)
This systematic review will be part of the OPEN Pro-
ject (To Overcome failure to Publish nEgative fiNdings)
which was developed with the goal of elucidating the
scope of non-publication of studies through a series of
systematic reviews. In an earlier issue of this journal
(‘Systematic Reviews’), our group has already published a
protocol for a systematic review which evaluates the ex-
tent of non-publication of research studies, which were
approved by ethics committees, registered in trial regis-
tries or presented as conference abstracts [8].
Methods/Design
Search methods for identification of methodological
research projects
To identify the relevant research evidence we will con-
duct electronic literature searches in the following data-
bases: Ovid Medline (1946 to present), Ovid Medline
Daily Update, Ovid Medline in process & other non-
indexed citations, Ovid Embase (1980 to present), The
Cochrane Library (most current issue) and Web of
Science. No language restrictions will be applied.
In addition, the bibliographies of any eligible articles
identified will be checked for additional references and
citation searches will be carried out for all included ref-
erences using ISI Web of Knowledge.
A search strategy for the electronic literature search in
Ovid Medline has already been designed with the sup-
port of a librarian/information specialist. This strategy
was translated as appropriate for the other databases
(for the full search strategies see Appendix A). In
addition, we will contact various experts in the field for
further eligible studies.
Data collection and analyses
Selection of methodological research projects
A methodological research project will be considered eli-
gible for inclusion in this systematic review if it reviews
a cohort of meta-analyses (that is, more than one meta-
analyses) that:
▪ compare pooled effect estimates of meta-analyses of
health care interventions according to publication
status (that is, published versus unpublished studies
or gray literature) or
▪ examine whether the inclusion of unpublished studies
or gray literature impacts the overall findings or
conclusions of a meta-analyses
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that appeared in peer-reviewed journals. Our working
definition of gray literature will correspond to the
definitions used by the authors of eligible methodo-
logical research projects and which also conforms to the
definition of ‘gray literature’ described earlier in this
protocol (see Background). A meta-analysis is defined as
the calculation of a summary estimate of treatment
effect by pooling the results of two or more studies.
Data extraction
A specifically designed data extraction form will be
developed and two reviewers will independently extract
all relevant data from eligible methodological research
projects. The following information will be collected:
1. Characteristics of the methodological research
project
a. Baseline data (for example, author names,
affiliation, language and year of publication,
funding, type of report (for example, full
publication, abstract))
b. Area of health care/medical specialty
c. Number of meta-analyses included
2. Characteristics of the meta-analyses included in the
methodological research project
a. Type of meta-analyses (for example, individual
patient data meta-analyses)
b. Number of studies included in meta-analyses
(overall, median, range)
c. Number of participants included in meta-analyses
(overall, median, range)
d. Main purpose of meta-analyses (efficacy versus
safety)
e. Source used to retrieve unpublished studies,
studies published in the gray literature and
published studies
3. Characteristics of the studies included in the meta-
analyses
a. Number of unpublished studies, studies published
in the gray literature and published studies
b. Number of participant in unpublished studies, in
studies published in the gray literature and in
published studies
c. Number of statistically significant positive or
negative unpublished studies, studies
published in the gray literature and published
studies
d. Type of unpublished studies (for example,
RCTs, observational studies), studies
published in the gray literature (for example,
abstracts, dissertation, letter, book chapters)
and published studies (for example, RCTs,
observational studies)e. Year of publication of unpublished studies,
studies published in the gray literature and
published studies
f. Language and country of unpublished studies,
studies published in the gray literature and
published studies
g. Funding source of unpublished studies, studies
published in the gray literature and published
studies
h. Type of data source in which gray, unpublished
and published studies were identified
i. Methodological quality (for example, blinding,
follow-up time, sample size calculation) of
unpublished studies, studies published in
the gray literature and published studies
(this aspect can only be evaluated if the
methodological research project provides
enough information)Assessment of validity
We will systematically consider the validity and genera-
lizability of the identified evidence provided by each of
the methodological research projects by evaluating the
following aspects:
1. Internal validity:
a. Role of confounding factors: The results of
published studies may differ from those of
unpublished studies because of factors other than
publication status, such as study design, type of
participants, characteristics of the intervention,
and methodological quality; in this context, did
the researcher of the meta-analyses select
comparison groups that were matched (for
example, did the unpublished studies or studies
published in the gray literature share similar
aims, designs, and sample sizes as the published
ones)?; if not, were suitable adjustments for
potentially confounding factors made?
b. Definition of publication status: Are explicit
criteria given to categorize or define unpublished
studies, studies published in the gray literature
and published studies?
c. Selection process: Are search criteria given to
identify unpublished studies, studies published in
the gray literature and published studies?
2. External validity (generalizability):
a. Did the researcher of the methodological research
project select a broad-ranging sample of
meta-analyses that reflect the current
literature in the field of interest (for example,
in terms of size, diversity of topic)?
b. How was the sample determined (for example,
random sample)?
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independently?
d. Did the researchers provide a complete dataset
(regarding the characteristics of the
methodological research project and included
meta-analyses)?Outcome measures
1. The extent to which the effect estimate in a
meta-analyses changes with the inclusion or
exclusion of unpublished studies and gray
literature (quantitative measurement). If possible,
we will calculate a ratio of risks or odds ratios
between the results of unpublished studies and
studies published in the gray literature and the
results of published studies and estimate the
percentage change (pooled risk ratio from
unpublished studies and gray literature divided by
pooled risk ratio from published studies). A
weighted pooled overall estimate will be
calculated taking into account number of studies,
participants and events.
2. The impact of the inclusion of unpublished studies
or studies published in the gray literature on
conclusions of meta-analyses (qualitative
measurement). The impact will be estimated by
calculating the proportion of meta-analyses which
show a change in their conclusions according to
publication status of the included studies;
categorization will be as follows:
a. Change from negatively significant to positively
significant
b. Change from inconclusive to positively significant
c. Change from positively significant to inconclusive
d. Change from negatively significant to
inconclusive
e. Change from inconclusive to negatively
significant
f. Change from positively significant to negatively
significant
g. Change from not clinical relevant to clinical
relevant
h. Change from not clinical relevant to inconclusive
i. Change from clinical relevant to inconclusive
j. Change from clinical relevant to not clinical
relevant
k. Change from inconclusive to clinical relevant
l. Change from inconclusive to not clinical relevantSignificance and clinical relevance will be defined
according to the definitions provided in the methodo-
logical research project.Unit of analyses issues
The anticipated unit of analyses is the meta-analyses in-
cluded in the methodological research project.
Assessment of heterogeneity
Heterogeneity for pooled outcome measures will be
assessed by standard methods including Chi2-test and
calculation of the I2 value [9].
Assessment of reporting biases
Funnel plots will be used to assess the association be-
tween point estimates of log odds ratio (a measure of
extent of association between meta-analyses’ characteris-
tics and change in summary estimates) and a measure of
precision if more than ten methodological research pro-
jects provide necessary information. Funnel plots will be
visually assessed and appropriate formal statistical tests
following recommendations formulated by Sterne et al.
will be used to test for asymmetry [5]. In the instance of
suspected reporting bias authors will be contacted.
Data synthesis
Data synthesis will involve a combination of descriptive
and statistical summaries of the impact of the inclusion
or exclusion of unpublished studies and gray literature
on the results of meta-analyses (identified by methodo-
logical research projects).
The decision on whether or not to combine the results
of the included methodological research projects will
depend on the assessment of heterogeneity. Where
methodological research projects will be judged to be
sufficiently homogenous in their design a meta-analyses
of these research projects will be carried out. The esti-
mated ratios of unpublished and published in the gray
literature only versus published treatment effects gener-
ated from each methodological evaluation will then be
used to summarize the overall difference in risk ratios
between unpublished and published in the gray literature
only and published studies. The 95% confidence interval
for the combined effect will be estimated using a ran-
dom effects model.
Subgroup analyses and investigation of heterogeneity
The following subgroup analyses are planned:
1. On the level of the methodological research project
a. Number of meta-analyses included in the
methodological research project
b. Number of participants included in the
methodological research project
2. On the level of the meta-analyses
a. Number of studies (unpublished studies versus
studies published in the gray literature versus
both)
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(unpublished studies versus studies published in
the gray literature versus both)
c. Design of studies (unpublished studies versus
studies published in the gray literature versus
both)
d. Source of database: gray literature (for example,
conference abstracts or research letters)
published in an easily accessible database versus
unpublished studies for which immense efforts
are required to be identified (for example, contact
with pharmaceutical industry)
e. Type of research work (drug versus non-drug
studies, clinical research versus basic research)
f. Area of health careSensitivity analyses
No sensitivity analyses are planned. However, should the
instance arise where a methodological research project
with doubtful eligibility is identified (as determined by
individual review and analyses of the validity of the
methodological research project), sensitivity analyses
may be undertaken. Possible sensitivity analyses may be
based on the following:
▪ Methodological quality/validity of the methodological
research project; only methodological research projects
with low risk of bias will be considered. A methodological
research project will be of high risk of bias when the
external validity and/or the validity of the included meta-
analyses are doubtful.
Discussion
This systematic review seeks to comprehensively synthe-
size the growing body of research that is related to the
impact of including unpublished studies and studies
published in the gray literature in meta-analyses. By
considering multiple characteristics and potential con-
founders related to unpublished studies and studies
published in the gray literature, we hope to identify suffi-
cient evidence to conclude whether (or to what extent)
inclusion of unpublished studies and studies published
in the gray literature has an impact on the pooled effect
estimates and the conclusions from a meta-analyses. The
findings, including risk factors for unpublished studies
and studies published in the gray literature, will have
important implications for researchers conducting meta-
analyses since they need to be informed about the im-
pact and extent of (not) including unpublished and gray
studies in meta-analyses. In addition, this systematic re-
view in combination with the results of other systematic
reviews that are part of the OPEN Project will serve to
raise awareness about the impact of publication bias and
the complexity of this issue. These reviews will alsoserve as a foundation for a recommendations workshop
which will enable key members of the biomedical re-
search community (for example, funders, research ethics
committees, and journal editors) to develop future pol-
icies and guidelines to lessen the frequency of non-
publication and related biases.
We acknowledge that more than half of all systematic re-
views do not involve meta-analysis in their analyses. Des-
pite the fact that our main outcomes focus on the impact
of unpublished and gray studies on pooled effect estimates
in meta-analyses, our findings will also be valuable for sys-
tematic reviews. It is obvious, if we find a statistical differ-
ence in the pooled effect estimates in meta-analyses, it is
also likely that gray and unpublished literature impacts
descriptive results of systematic reviews. Beside effect esti-
mates, we will also evaluate differences in the methodo-
logical quality and study characteristics (such as number of
participants, language or methodological quality) between
unpublished, gray and published studies. These results will
also be valuable for systematic reviews to appraise the
potential impact of publication bias.
Appendix A
Search Strategy for OvidSP MEDLINE (search strategy will
be adapted for other databases)
Line 10 to 14 and 16 to 35 are not shown because they are
part of the search strategy for our 1st systematic review [8]





5. exp manuscripts as topic/
6. ((data or finding? or information or evidence or study
or studies or trial? or paper? or article? or report* or
literature or work or manuscript? or abstract* or
result?) adj6 (unpublish* or un-publish* or unreport*
or un-report* or nonpublish* or non-publish* or
nonpublicat* or non-publicat* or (publication? adj3
rate?) or "not publish*")).ti,ab.
7. (underreport* or under-report* or selective report* or
selective publish* or selective publicat* or (final* adj2
(report* or publish* or publicat* or manuscript? or
paper? or article?)) or (full? adj2 (report* or publish*
or publicat* or manuscript? or paper? or article?)) or
(subsequent* adj2 (report* or article? or paper? or
publi* or manuscript?)) or (sub-sequent* adj2 (report?
or article? or paper? or publi* or manuscript?)) or
(complete* adj2 (report* or article? or paper? or
publish* or publicat* or manuscript?))).ti,ab.
8. (bias* adj3 (publish* or publicat*)).ti,ab.
9. or/1-8
15. exp animals/ not humans/
Table 1 OPEN Consortium
Contributor Participating Institution
Antes, Gerd German Cochrane Center, Institute of Medical Biometry
and Medical Informatics University Medical Center,
Freiburg, Germany
Bassler, Dirk Center for Pediatric Clinical Studies, University Medical
Center Tuebingen, Germany
Bertele, Vittorio Department of Epidemiology, Mario Negri Institute for
Pharmacological Research, Italy
Bonfill, Xavier The Clinical Epidemiology & Public Health Department
at the Hospital de la Santa Creu i Sant Pau, Spain
Bouesseau,
Marie-Charlotte
World Health Organization, Geneva, Switzerland
Boutron,
Isabelle
INSERM U738 research unit, Paris Descartes University,
Paris, France
Gallus, Silvano Department of Epidemiology, Mario Negri Institute for
Pharmacological Research, Italy
Garattini, Silvio Department of Epidemiology, Mario Negri Institute for
Pharmacological Research, Italy
Ghassan, Karam World Health Organization, Geneva, Switzerland
La Vecchia,
Carlo
Department of Epidemiology, Mario Negri Institute for
Pharmacological Research, Italy
Lang, Britta German Cochrane Center, Institute of Medical Biometry




CELLS (Centre for Ethics and Law in Life Sciences),
Hannover Medical Scholl, Hannover, Germany
Kleijnen, Jos Kleijnen Systematic Reviews Ltd., York, United Kingdom
Kulig, Michael Federal Joint Committee, Berlin, Germany
Malicki, Mario University of Split School of Medicine, Split, Croatia
Marusic, Ana University of Split School of Medicine, Split, Croatia
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37. Guidelines as Topic/ or Practice Guidelines as
Topic/
38. exp Clinical Trials as Topic/
39 meta-analysis.pt.
40. (guideline or practice guideline).pt.
41. (guideline? or metaanaly* or meta-analy* or
metanaly* or meta-synthe* or metasynthe* or
meta-regressi* or metaregressi*).ti,ab.
42. (systematic* adj3 (review* or overview*)).ti,ab.
43. exp Technology Assessment, Biomedical/
44. (health technology assessment? or HTA).ti,ab.
45. or/36-44
46. 9 and 45
47. 46 not 15
48. ((implication? or impact? or influenc* or effect? or
differen*) adj6 (publication bias* or unpublish* or
un-publish* or unreport* or un-report* or
nonpublish* or non-publish* or nonpublicat* or
non-publicat* or "not publish*")).ti,ab.
49. ((implication? or impact? or influenc* or effect? or
differen*) adj6 (selective report* or selective publish*
or selective publicat* or (final* adj2 (report* or
publish* or publicat* or manuscript? or paper?
or article?)) or (full? adj2 (report* or publish* or
publicat* or manuscript? or paper? or article?))
or (subsequent* adj2 (report* or article? or paper? or
publi* or manuscript?)) or (sub-sequent* adj2
(report? or article? or paper? or publi* or
manuscript?)) or (complete* adj2 (report* or article?
or paper? or publish* or publicat* or manuscript?)))).
ti,ab.
50. ((unpublish* or un-publish* or unreport* or un-
report* or nonpublish* or non-publish* or
nonpublicat* or non-publicat* or "not publish*")
adj6 publish*).ti,ab.
51. (underreport* or under-report* or selective report* or
selective publish* or selective publicat* or (final* and
(report* or publish* or publicat* or manuscript? or
paper? or article?)) or (full? and (report* or publish*
or publicat* or manuscript? or paper? or article?)) or
(subsequent* and (report* or article? or paper? or
publi* or manuscript?)) or (sub-sequent* and (report?
or article? or paper? or publi* or manuscript?)) or
(complete* and (report* or article? or paper? or
publish* or publicat* or manuscript?))).ti.
52. (unpublish* or un-publish* or unreport* or un-
report* or nonpublish* or non-publish* or
nonpublicat* or non-publicat* or "not publish*" or
bias*).ti.
53. or/48-52
54. 47 and 53
55. 47 and (3 or 4)
56. 47 and (36 or 37)57. 56 and (6 or 7)
58. *meta-analysis as topic/
59. *Guidelines as Topic/ or *Practice Guidelines as
Topic/
60. 47 and (58 or 59)
61. (6 or 7) and (3 or 8)
62. 54 or 55 or 57 or 60 or 61
63. (unpublish* or un-publish* or unreport* or un-
report* or nonpublish* or non-publish* or non-
publicat* or non-publicat* or "not publish*").ti,ab.
64. 7 or 63
65. 62 and 64
66. 36 or 37
67. 3 and 66
68. 65 or 67
69. 68 not 15
70. remove duplicates from 69Appendix B
OPEN Consortium
Table 1 shows OPEN Consortium.
Table 1 OPEN Consortium (Continued)
Meerpohl,
Joerg
German Cochrane Center, Institute of Medical Biometry





Center for Pediatric Clinical Studies, University
Medical Center Tuebingen, Germany
Pardo, Hector The Clinical Epidemiology & Public Health Department
at the Hospital de la Santa Creu i Sant Pau, Spain
Perleth,
Matthias
Federal Joint Committee, Berlin, Germany
Ravaud,
Philippe
INSERM U738 research unit, Paris Descartes University,
Paris, France
Reis, Andreas World Health Organization, Geneva, Switzerland
Schmucker,
Christine
German Cochrane Center, Institute of Medical Biometry




German Cochrane Center, Institute of Medical Biometry
and Medical Informatics University Medical Center,
Freiburg, Germany
Strech, Daniel CELLS (Centre for Ethics and Law in Life Sciences),
Hannover Medical Scholl, Hannover, Germany
Trinquart,
Ludovic
INSERM U738 research unit, Paris Descartes University,
Paris, France
Urrútia, Gerard The Clinical Epidemiology & Public Health Department
at the Hospital de la Santa Creu i Sant Pau, Spain
Von Elm, Erik German Cochrane Center, Institute of Medical Biometry




Sideview, Princes Risborough, United Kingdom
Wieland,
Alexandra
Federal Joint Committee, Berlin, Germany
Wolff, Robert Kleijnen Systematic Reviews Ltd., York, United Kingdom
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